Adaption of the Dexamethasone Symptom Questionnaire in a Multiple Myeloma Population: Item generation, content and face validity of the ‘Steroid Symptom Questionnaire – Multiple Myeloma’ (SSQ-MM)

Corticosteroids (steroids) play a central role in the treatment of MM and are widely recognised to cause a wide range of side effects that adversely impact health related quality of life (HRQoL). Patient reported outcome measures (PROMs) are tools that enable patients to report their health status and the presence and severity of symptoms. A range of PROMs are available to assess symptoms in MM but no such tool exists to measure the impact of steroids in this population. The Dexamethasone Symptom Questionnaire Chronic (DSQ-C) is an 18-item measure, initially developed to determine the incidence and severity of symptoms experienced by cancer patients given dexamethasone prophylaxis for moderately emetic chemotherapy.
Source: Clinical Lymphoma, Myeloma and Leukemia - Category: Hematology Authors: Source Type: research